Wall Street’s Key Stock Analysts Research Report, All Buys

Wall Street’s Key Stock Analysts Research Report, All Buys

#buys #bullish #WallStreet #analysts

$CF $EXK $ETSY $GOCO $GSS $HL $NAK $SWCH $VRNA

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy

Below is our list for Tuesday, 11 August, as follows:

CF Industries Holdings Inc. (NYSE:CF) was raised to Buy from Neutral at Citigroup and its target price was raised to 38 from 29.

Endeavour Silver Corp. (NYSE:EXK) was reiterated as Buy and its price target was raised to 5.25 from 3.25 at HC Wainwright.

Etsy Inc. (NASDAQ:ETSY) Citigroup reiterated it as Buy and raised its target price to 170 from 100.

GoHealth Inc. (NASDAQ:GOCO) has seen its quiet period end, with a 1.6% gain to 17.25 Friday and a 2% gainer to 17.50 Monday. Truist started it as Buy with a 26 target price.

Golden Star Resources Ltd. (NYSEARCA:GSS) was reiterated as Buy and its price target was raised to 6.75 from 5.25 at HC Wainwright.

Hecla Mining Co. (NYSE:HL) was reiterated as Buy and its price target was raised to 7.00 from 4.25 at HC Wainwright.

Northern Dynasty Minerals Ltd. (NYSEARCA:NAK) was reiterated as Buy and its price target was raised to 3.50 from 2.75 at HC Wainwright.

Switch Inc. (NYSE:SWCH) was reiterated as Buy and its target price was raised to 23 from 22 at Citigroup

Verona Pharma PLC (NASDAQ:VRNA) was started with a Buy rating and a 17 price target at Canaccord Genuity.

Have a healthy day, Keep the Faith!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.